Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment

2022 | journal article; erratum. A publication with affiliation to the University of Göttingen.

Original publication

Jump to: Cite & Linked | Documents & Media | Details | Version history

Cite this publication

​Publisher Correction: Dalbavancin: novel candidate for COVID-19 treatment​
Hoffmann, M.; Jin, Y. & Pöhlmann, S. ​ (2022) 
Cell Research,.​ DOI: https://doi.org/10.1038/s41422-022-00713-y 

Copy

Further links

Documents & Media

document.pdf263.45 kBAdobe PDF

License

Published Version

Attribution 4.0 CC BY 4.0

Details

Authors
Hoffmann, Markus; Jin, Yeonhwa; Pöhlmann, Stefan 
Issue Date
2022
Journal
Cell Research 
Organization
Fakultät für Biologie und Psychologie ; Deutsches Primatenzentrum ; Abteilung Infektionsbiologie 
eISSN
1748-7838
Language
English

Export Metadata

Refman EndNote BibTeX RefWorks Excel CSV

Reference

Citations


Social Media